Emcure Pharmaceuticals receives upgrade in credit ratings from CRISIL
Emcure Pharmaceuticals has received upgrade in credit ratings from CRISIL for bank facilities of Rs 2,475.43 crore of the company as under:
Long term rating - CRISIL AA-/ Stable
Short term rating - CRISIL A1+
Low Price Shares
0 mins read . Dec 18, 2024
Nifty 50 Top 10 Stocks
0 mins read . Dec 18, 2024
Best Stocks in 2025
0 mins read . Dec 18, 2024
Explore our products
Unlimited Trading starting at ₹249
Open Trading Account
